These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33316731)

  • 1. Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Ojwach DBA; Madlala P; Gordon M; Ndung'u T; Mann JK
    Virology; 2021 Feb; 554():1-8. PubMed ID: 33316731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.
    Tekeste SS; Wilkinson TA; Weiner EM; Xu X; Miller JT; Le Grice SF; Clubb RT; Chow SA
    J Virol; 2015 Dec; 89(23):12058-69. PubMed ID: 26401032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) in Facilitating IN Assembly and Nonenzymatic Function through the IN Precursor Form with Reverse Transcriptase.
    Takahata T; Takeda E; Tobiume M; Tokunaga K; Yokoyama M; Huang YL; Hasegawa A; Shioda T; Sato H; Kannagi M; Masuda T
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase.
    Wilkinson TA; Januszyk K; Phillips ML; Tekeste SS; Zhang M; Miller JT; Le Grice SF; Clubb RT; Chow SA
    J Biol Chem; 2009 Mar; 284(12):7931-9. PubMed ID: 19150986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
    Abram ME; Parniak MA
    J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other.
    Tasara T; Maga G; Hottiger MO; Hübscher U
    FEBS Lett; 2001 Oct; 507(1):39-44. PubMed ID: 11682056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and protease.
    Haas G; Samri A; Gomard E; Hosmalin A; Duntze J; Bouley JM; Ihlenfeldt HG; Katlama C; Autran B
    AIDS; 1998 Aug; 12(12):1427-36. PubMed ID: 9727563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
    Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
    J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis.
    Padow M; Lai L; Deivanayagam C; DeLucas LJ; Weiss RB; Dunn DM; Wu X; Kappes JC
    J Virol; 2003 Oct; 77(20):11050-9. PubMed ID: 14512553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.
    Brumme ZL; Li C; Miura T; Sela J; Rosato PC; Brumme CJ; Markle TJ; Martin E; Block BL; Trocha A; Kadie CM; Allen TM; Pereyra F; Heckerman D; Walker BD; Brockman MA
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):100-8. PubMed ID: 21124229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells.
    Balakrishnan M; Yant SR; Tsai L; O'Sullivan C; Bam RA; Tsai A; Niedziela-Majka A; Stray KM; Sakowicz R; Cihlar T
    PLoS One; 2013; 8(9):e74163. PubMed ID: 24040198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
    EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
    Hu Z; Kuritzkes DR
    J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review).
    Menéndez-Arias L; Mas A; Domingo E
    Viral Immunol; 1998; 11(4):167-81. PubMed ID: 10189185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Uncoating and Reverse Transcription Require eEF1A Binding to Surface-Exposed Acidic Residues of the Reverse Transcriptase Thumb Domain.
    Rawle DJ; Li D; Swedberg JE; Wang L; Soares DC; Harrich D
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses.
    Pham HT; Mesplède T; Wainberg MA
    Retrovirology; 2016 Apr; 13(1):31. PubMed ID: 27130466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation, D404N, in the connection subdomain of reverse transcriptase of HIV-1 CRF08_BC subtype confers cross-resistance to NNRTIs.
    Zhang XM; Wu H; Zhang Q; Lau TC; Chu H; Chen ZW; Jin DY; Zheng BJ
    J Antimicrob Chemother; 2015 May; 70(5):1381-90. PubMed ID: 25637519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance.
    Van den Eede P; Van Wesenbeeck L; Verlinden Y; Feyaerts M; Smits V; Verheyen A; Vanhooren L; Deloof A; Villacian J; Pattery T
    Methods Mol Biol; 2013; 1030():37-55. PubMed ID: 23821259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.